MDBIF.US Medibio Limited

Healthcare Health Care Technology USA Stocks
0.0029 USD
Close of Nov 15, 2026
0.0025 0.0278
Market cap
USD 3.35M
P/E
-
P/B
0.31x
ROE
-54.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is MDBIF.US undervalued?

Graham number

The Graham number of Medibio Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medibio Limited fundamental analysis

No fundamental analysis for Medibio Limited yet.

Medibio Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medibio Limited

TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is b…

Full company profile